Peripheral vascular devices market seen reaching $13.15B by 2030

The peripheral vascular devices and equipment market is projected to grow from $10.56 billion in 2026 to $13.15 billion by 2030, driven by rising peripheral artery disease, aging populations and wider use of minimally invasive treatments. North America held the largest share in 2025 as healthcare spending and device innovation continue to support demand.

Why it matters: - Peripheral vascular devices and equipment are used to diagnose and treat diseases that restrict blood flow outside the heart and brain. - Demand is rising as peripheral vascular disease becomes more common and health systems expand access to catheter-based and minimally invasive care. - The category sits at the intersection of chronic disease treatment, hospital investment and device innovation.

What happened: - The Business Research Company released its "Peripheral Vascular Devices And Equipment Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The market was estimated at $10.29 billion in 2025 and is projected to reach $10.56 billion in 2026. - The report forecasts the market will climb to $13.15 billion by 2030. - North America held the largest share of the global market in 2025. - Western Europe ranked second in market size.

The details: - The market is growing on the back of higher peripheral artery disease incidence, an aging global population and greater adoption of catheter-based therapies. - Hospital infrastructure investment and the expansion of interventional cardiology services are also supporting demand. - The report points to faster growth ahead from increased use of minimally invasive vascular treatments and bioresorbable materials. - Outpatient vascular procedures, precision-guided interventions and new peripheral stent technologies are also expected to help lift sales. - The report highlights wider adoption of drug-coated vascular devices, more frequent use of minimally invasive endovascular techniques and stronger demand for advanced atherectomy systems. - Image-guided peripheral interventions and a focus on long-term device patency are among the main trends in the forecast period. - The analysis covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa, in addition to North America and Western Europe. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample is available through the company’s sample page. - The full report is available at the company’s market report page.

Between the lines: - The forecast implies a steadier, not explosive, expansion in the near term, followed by faster growth later in the decade. - The combination of aging populations, outpatient care and image-guided procedures suggests the market is shifting toward less invasive treatment pathways. - Higher healthcare spending can translate into more equipment purchases, especially when governments and providers prioritize diagnosis and treatment capacity.

What's next: - The market is expected to keep expanding toward 2030 as hospitals and clinics adopt newer vascular devices and techniques. - Drug-coated devices, atherectomy systems and endovascular approaches are likely to gain more traction if the forecast trends hold. - Ongoing healthcare spending growth will remain a key variable for device demand across major regions.

The bottom line: - Peripheral vascular devices are positioned for moderate growth now and stronger momentum later, with North America still leading the market.